PPARA and obesity due to melanocortin 4 receptor deficiency: Anti-diabetic and anti-obesity effects of CA and CGA supplementation involved hepatic PPARα activation, increased insulin production and inhibition of key enzymes from the lipid biosynthesis that produced body weight reduction and improved metabolic parameters compared to high-fat diet-induced obese mice [38].